Valmagol 200mg Davipharm medicine treats all painful and local pain (10 blisters x 10 tablets)

Dosage form Box of 10 blisters x 10 tablets
Specifications Magnesium valproat

Ingredient

Composition information	Content
Magnesium valproat	200mg

Uses

Mensal or local epilepsy:

Mass epilepsy:

Consciousness.

Simple.

complex.

Before taking Valmagol 200mg Davipharm medicine treats all painful and local pain (10 blisters x 10 tablets)

How to use

Used orally. The drug should be used while eating.

Dosage

Adults: The first dose of 600 mg/ 24 hours, divided into 2-4 times, followed by every 3 days increased by 200 mg (increasing gradually to the cutting dose). Average: 20-30 mg/kg body weight/24 hours, divided into 2-4 times.

Children: 15-30 mg/kg body weight/24 hours, divided into 2-3 times.

Symptoms: mild coma to deep, reducing muscle tone, reducing reflexes, pupils shrinking, reducing respiratory autonomy. Hemodiastery or blood change when severe.

If you forget to use the medication on time, do not use the dosage at a late day, should continue to use the normal dose the next day in the course.

Side Effects

The risk of teratogenicity. This phenomenon often occurs when using polygon or sudden increase in dosage. liver.

Warnings

Precautions when using

Do not stop the drug suddenly. Abstain from alcohol. Avoid driving and operating machinery. In this case, it is advisable to perform a complete biological statistics (especially prothrombin ratio), adjust the dose and redo tests depending on the results of the biological parameters. set) should be performed before treatment, as well as before surgery or in case of blood bruises or spontaneous bleeding.

in children should avoid prescribing simultaneously with salicylat derivatives.

Drug interaction

The effect of valproat on other drugs:

- Neurological drugs, Mao inhibitors, antidepressants: Valproat increases the effectiveness of the above drugs, thus reducing the dose of these drugs as needed.

- Phenobarbital: Valproat increases phenobarbital levels. Clinical monitoring should be monitored in the first 15 days of drug coordination and phenobarbital dose reduction when sedative symptoms.

- Primidon: Valproat increases the concentration of primidon and increases its unwanted effects. Clinical monitoring and dose adjustment when needed.

- Phenytoin: Valproat increases the total level of phenytoin in plasma and free phenytoin.

- Lamotrigin: Valproat reduces Lamotrigin metabolism, so the dose is needed.

Effect of other drugs on Valproat:

- Phenobarbital, Phenytoin, Carbamazepine reduces the concentration of Valproat, therefore, the dose must be reduced according to plasma concentrations when combined treatment.

- Mefloquin increases Valproat metabolism and has epilepsy.

- When used in combination with Valproat with strong protein-connected substances such as aspirin, it will increase the concentration of free valproot.

- Valproat concentration increases (due to reduced metabolism in the liver) when used in combination with erythromycin or cimetidine.

Storage

in a dry place. Avoid light, temperature not exceeding 30 degrees C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.